Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before

Bridge2AI:声音作为健康的生物标志物 - 建立一个符合道德规范的生物声学数据库,以前所未有的方式了解疾病

基本信息

  • 批准号:
    10473236
  • 负责人:
  • 金额:
    $ 381.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Our group aims to integrate the use of voice as biomarker of health in clinical care by generating a substantial multi-institutional, ethically sourced, and diverse voice database linked to multimodal health biomarkers to fuel voice AI research and build predictive models to assist in screening, diagnosis, and treatment of a broad range of diseases. Data collection will be made possible by software through a smartphone application linked to electronic health records (EHR) and other health biomarkers such as radiomics, and genomics, and supported by federated learning technology to protect data privacy. Based on the existing literature and ongoing research in different fields of voice research, our group has identified 5 disease categories for which voice changes have been associated to specific diseases and around which we aim to center the data acquisition efforts: 1. Vocal Pathologies (Laryngeal cancers, Vocal fold paralysis, Benign laryngeal lesions) 2. Neurological and Neurodegenerative Disorders (Alzheimer’s, Parkinson’s, Stroke, ALS) 3. Mood and Psychiatric Disorders (Depression, Schizophrenia, Bipolar Disorders) 4. Respiratory disorders (Pneumonia, COPD, Heart Failure, OSA) 5. Pediatric diseases (Autism, Speech Delay) Specific Aim #1: Data Acquisition Module: - To build a multi-modal, multi-institutional, large scale, diverse and ethically sourced human voice database linked to other biomarkers of health that is AI/ML friendly to fuel voice AI research Specific Aim #2: Standard Module: - To introduce the field of acoustic biomarkers by developing new standards of acoustic and voice data collection and analysis for voice AI research. Specific Aim #3: Tool Development and optimization - To develop a software and cloud infrastructure for automated voice data collection through a smartphone application that allows non-invasive, user-friendly, high quality voice data collection while minimizing human manipulation. This will include integrated acoustic amplifiers and acoustic quality standardization. - To implement Federated Learning technology to allow analysis of multi-institutional data while minimizing data sharing and preserving patient privacy Specific Aim #4: Ethics Module - To integrate existing scholarship, tools, and guidance with development of new standard and normative insights for identifying, anticipating, addressing, and providing guidance on ethical and trustworthy issues from voice data generation and AI/ML research and development to clinical adoption and downstream health decisions and outcomes. - To develop new guidelines for consenting to voice data collection, voice data sharing and utilization in the context of voice AI technology Specific Aim # 5: Teaming Module: - To build bridges between the medical voice research world, the acoustic engineers, and the AI/ML world to promote the integration of tangible clinical application for Voice AI algorithms Specific Aim #6: Skills and Workforce Development Module - To develop a unique curriculum on voice biomarkers of health and the development, validation, and implementation for AI models that are FAIR and CARE - To create a community of voice AI researchers, especially those from underserved communities, and foster collaborations to promote application of ML for Voice Research - To engage a broad range of learners with competency assessment and mentorship
我们的团队旨在通过创建一个与多模式健康生物标志物相关联的大量多机构、伦理来源和多样化的语音数据库,将语音作为健康生物标志物在临床护理中的应用整合起来,以推动语音人工智能研究,并建立预测模型,以协助筛查、诊断和治疗广泛的疾病。数据收集将通过与电子健康记录(EHR)和其他健康生物标志物(如放射组学和基因组学)相关联的智能手机应用程序的软件实现,并得到联邦学习技术的支持,以保护数据隐私。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yael Emilie Bensoussan其他文献

Yael Emilie Bensoussan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yael Emilie Bensoussan', 18)}}的其他基金

Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before
Bridge2AI:声音作为健康的生物标志物 - 建立一个符合道德规范的生物声学数据库,以前所未有的方式了解疾病
  • 批准号:
    10858564
  • 财政年份:
    2022
  • 资助金额:
    $ 381.73万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 381.73万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了